SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NeoGenomics, Inc. (NGNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: caly who wrote (17)4/15/2009 9:02:52 AM
From: Chris Forte  Read Replies (2) of 30
 
Fourth Quarter 2008 Highlights:
-- Revenue of $5.9 million, an increase of 56% year-over-year from Q4 07
-- 17.2% sequential increase in revenues in Q4 08 vs. Q3 08
-- Avg. Rev/Requisition increased 13.7% in Q4 08 from Q4 07
-- Avg. Rev/Test increased 9.6% in Q4 08 from Q4 07
-- Development of in-house molecular testing capability

Fiscal Year 2008 Highlights:
-- Revenue of $20.0 million, an increase of 74% year-over-year from FY 07
-- Avg. Rev/Requisition increased 15% in FY 08 from FY 07
-- Avg. Rev/Test increased 12.3% in FY 08 from FY 07
-- Days Sales Outstanding (DSO) declined to 45 days on 12/31/08 from 79
on
12/31/07
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News